Coultreon Biopharma

Transforming lives with groundbreaking treatments

Coultreon Biopharma is a biotech company in Leuven, United States, founded in 2025. It has raised $125.0M across 1 round, most recently a $125.0M Series A in April 2026.

Headquarters
Leuven
Employees
11–50
Founded
2025
Business Model
B2B
Total Funding
$125.0M
Last Round
$125.0M Series AApr 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 5 investors for this company. to use credits for reveals, or explore the API.

About

Coultreon Biopharma (formerly Onco3R Therapeutics) is a Leuven, Belgium-based clinical-stage biotech founded in 2025 developing precision medicines for autoimmune and inflammatory diseases. Its lead asset COL-5671 is a selective SIK3 inhibitor that completed Phase 1 with favorable safety and pharmacokinetic data, targeting ulcerative colitis and other immune-mediated conditions with a once-daily oral therapy.

Funding History

Data from Indexed.vcUpdated
Series ASeries AApr 2026
$125.0M

Investors

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×1
  • Frontend ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Coultreon Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/coultreon-biopharma"><img src="https://indexed.vc/api/badge/company/coultreon-biopharma" alt="Coultreon Biopharma on Indexed.vc" width="260" height="76" /></a>